BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21846748)

  • 1. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
    Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
    J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
    Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
    Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration.
    Meurs KM; Friedenberg SG; Williams B; Keene BW; Atkins CE; Adin D; Aona B; DeFrancesco T; Tou S; Mackay T
    Vet J; 2018 Feb; 232():16-19. PubMed ID: 29428085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
    Sudunagunta S; Green D; Christley R; Dukes-McEwan J
    J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8- to 10-Year Period.
    Birkegård AC; Reimann MJ; Martinussen T; Häggström J; Pedersen HD; Olsen LH
    J Vet Intern Med; 2016; 30(1):63-8. PubMed ID: 26578464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myxomatous mitral valve disease in the miniature poodle: A retrospective study.
    Meurs KM; Adin D; O'Donnell K; Keene BW; Atkins CE; DeFrancesco T; Tou S
    Vet J; 2019 Feb; 244():94-97. PubMed ID: 30825902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Variants at the Nebulette Locus Are Associated with Myxomatous Mitral Valve Disease Severity in Cavalier King Charles Spaniels.
    Mead SE; Beijerink NJ; O'Brien M; Wade CM
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
    Ljungvall I; Höglund K; Lilliehöök I; Oyama MA; Tidholm A; Tvedten H; Häggström J
    J Vet Intern Med; 2013; 27(5):1105-12. PubMed ID: 23865457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Echocardiographic Findings in an Aged Population of Cavalier King Charles Spaniels.
    Prieto Ramos J; Corda A; Swift S; Saderi L; De La Fuente Oliver G; Corcoran B; Summers KM; French AT
    Animals (Basel); 2021 Mar; 11(4):. PubMed ID: 33800666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987-1991).
    Beardow AW; Buchanan JW
    J Am Vet Med Assoc; 1993 Oct; 203(7):1023-9. PubMed ID: 8135932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
    Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
    J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
    Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
    J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.
    Zois NE; Moesgaard SG; Kjelgaard-Hansen M; Rasmussen CE; Falk T; Fossing C; Häggström J; Pedersen HD; Olsen LH
    Vet J; 2012 Apr; 192(1):106-11. PubMed ID: 21696985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
    Lu CC; Liu MM; Culshaw G; French A; Corcoran B
    J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease.
    Hezzell MJ; Boswood A; Chang YM; Moonarmart W; Elliott J
    Am J Vet Res; 2012 Nov; 73(11):1765-74. PubMed ID: 23106462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study.
    Pedersen HD; Kristensen BO; Lorentzen KA; Koch J; Jensen AL; Flagstad A
    Can J Vet Res; 1995 Oct; 59(4):294-8. PubMed ID: 8548691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.
    Moesgaard SG; Klostergaard C; Zois NE; Teerlink T; Molin M; Falk T; Rasmussen CE; Luis Fuentes V; Jones ID; Olsen LH
    J Vet Intern Med; 2012; 26(1):61-8. PubMed ID: 22151409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
    Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
    Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
    Reimann MJ; Fredholm M; Cremer SE; Christiansen LB; Meurs KM; Møller JE; Häggström J; Lykkesfeldt J; Olsen LH
    J Vet Intern Med; 2021 Nov; 35(6):2596-2606. PubMed ID: 34599615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs.
    Pedersen LG; Tarnow I; Olsen LH; Teerlink T; Pedersen HD
    Res Vet Sci; 2006 Jun; 80(3):336-42. PubMed ID: 16182327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.